191 related articles for article (PubMed ID: 16791669)
1. Application of pharmacokinetic-pharmacodynamic modelling in management of QT abnormalities after citalopram overdose.
Isbister GK; Friberg LE; Duffull SB
Intensive Care Med; 2006 Jul; 32(7):1060-5. PubMed ID: 16791669
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetic-pharmacodynamic modelling of QT interval prolongation following citalopram overdoses.
Friberg LE; Isbister GK; Duffull SB
Br J Clin Pharmacol; 2006 Feb; 61(2):177-90. PubMed ID: 16433872
[TBL] [Abstract][Full Text] [Related]
3. Population pharmacokinetics and pharmacodynamics of escitalopram in overdose and the effect of activated charcoal.
van Gorp F; Duffull S; Hackett LP; Isbister GK
Br J Clin Pharmacol; 2012 Mar; 73(3):402-10. PubMed ID: 21883384
[TBL] [Abstract][Full Text] [Related]
4. Activated charcoal decreases the risk of QT prolongation after citalopram overdose.
Isbister GK; Friberg LE; Stokes B; Buckley NA; Lee C; Gunja N; Brown SG; MacDonald E; Graudins A; Holdgate A; Duffull SB
Ann Emerg Med; 2007 Nov; 50(5):593-600, 600.e1-46. PubMed ID: 17719135
[TBL] [Abstract][Full Text] [Related]
5. Citalopram overdose: late presentation of torsades de pointes (TdP) with cardiac arrest.
Tarabar AF; Hoffman RS; Nelson L
J Med Toxicol; 2008 Jun; 4(2):101-5. PubMed ID: 18570170
[TBL] [Abstract][Full Text] [Related]
6. QTc interval prolongation associated with citalopram overdose: a case report and literature review.
Catalano G; Catalano MC; Epstein MA; Tsambiras PE
Clin Neuropharmacol; 2001; 24(3):158-62. PubMed ID: 11391127
[TBL] [Abstract][Full Text] [Related]
7. In response to Isbister et al.: Application of pharmacokinetic-pharmacodynamic modeling in management of QT abnormalities after citalopram overdose.
Manini A; Smith S; Moskovitz J; Nelson L
Intensive Care Med; 2007 Apr; 33(4):738; author reply 739. PubMed ID: 17279361
[No Abstract] [Full Text] [Related]
8. Medical toxicologists' practice patterns regarding drug-induced QT prolongation in overdose patients: a survey in the United States of America, Europe, and Asia Pacific region.
Othong R; Devlin JJ; Kazzi ZN
Clin Toxicol (Phila); 2015 May; 53(4):204-9. PubMed ID: 25706450
[TBL] [Abstract][Full Text] [Related]
9. A critical evaluation of the cardiac toxicity of citalopram: part 1.
Howland RH
J Psychosoc Nurs Ment Health Serv; 2011 Nov; 49(11):13-6. PubMed ID: 22007855
[TBL] [Abstract][Full Text] [Related]
10. Prolonged QTc interval due to escitalopram overdose.
Mohammed R; Norton J; Geraci SA; Newman DB; Koch CA
J Miss State Med Assoc; 2010 Dec; 51(12):350-3. PubMed ID: 21370605
[TBL] [Abstract][Full Text] [Related]
11. Effect of activated charcoal on citalopram-induced QT prolongation.
Greene SC; Brooks DE; Lovecchio F
Ann Emerg Med; 2008 Jul; 52(1):86-7; author reply 87-8. PubMed ID: 18565387
[No Abstract] [Full Text] [Related]
12. Citalopram Overdose: a Fatal Case.
Kraai EP; Seifert SA
J Med Toxicol; 2015 Jun; 11(2):232-6. PubMed ID: 25326372
[TBL] [Abstract][Full Text] [Related]
13. Clinical and ECG effects of escitalopram overdose.
van Gorp F; Whyte IM; Isbister GK
Ann Emerg Med; 2009 Sep; 54(3):404-8. PubMed ID: 19556032
[TBL] [Abstract][Full Text] [Related]
14. Clinical toxicology of citalopram after acute intoxication with the sole drug or in combination with other drugs: overview of 26 cases.
Jimmink A; Caminada K; Hunfeld NG; Touw DJ
Ther Drug Monit; 2008 Jun; 30(3):365-71. PubMed ID: 18520609
[TBL] [Abstract][Full Text] [Related]
15. Citalopram, QTc Prolongation, and Torsades de Pointes.
Tampi RR; Balderas M; Carter KV; Tampi DJ; Moca M; Knudsen A; May J
Psychosomatics; 2015; 56(1):36-43. PubMed ID: 25619672
[TBL] [Abstract][Full Text] [Related]
16. Drug monitoring of a case of citalopram overdosage.
Liotier J; Coudoré F
Drug Chem Toxicol; 2011 Oct; 34(4):420-3. PubMed ID: 21846175
[TBL] [Abstract][Full Text] [Related]
17. Prolonged QT Risk Assessment in Antipsychotic Overdose Using the QT Nomogram.
Berling I; Isbister GK
Ann Emerg Med; 2015 Aug; 66(2):154-64. PubMed ID: 25639523
[TBL] [Abstract][Full Text] [Related]
18. The population pharmacokinetics of citalopram after deliberate self-poisoning: a Bayesian approach.
Friberg LE; Isbister GK; Hackett LP; Duffull SB
J Pharmacokinet Pharmacodyn; 2005 Aug; 32(3-4):571-605. PubMed ID: 16307209
[TBL] [Abstract][Full Text] [Related]
19. A comparative study of QT prolongation with serotonin reuptake inhibitors.
Ojero-Senard A; Benevent J; Bondon-Guitton E; Durrieu G; Chebane L; Araujo M; Montastruc F; Montastruc JL
Psychopharmacology (Berl); 2017 Oct; 234(20):3075-3081. PubMed ID: 28770276
[TBL] [Abstract][Full Text] [Related]
20. Relative toxicity of selective serotonin reuptake inhibitors (SSRIs) in overdose.
Isbister GK; Bowe SJ; Dawson A; Whyte IM
J Toxicol Clin Toxicol; 2004; 42(3):277-85. PubMed ID: 15362595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
